Early sST2 Liberation after Implantation of a Left Ventricular Assist Device in Patients with Advanced Heart Failure.

Philipp OpfermannElisabeth SimaderAlessia FelliMichele BevilacquaCaroline HolaubekMartin DworschakMohamed MouhieddineDaniel ZimpferJan Hendrik AnkersmitBarbara Steinlechner

Published in: Journal of immunology research (2020)

colonisation were associated with higher mortality. Awareness of this early immune response can guide physicians in risk-benefit analysis.

Keyphrases

left ventricular assist device
heart failure
immune response
primary care
cardiovascular events
dendritic cells
left ventricular
risk factors
type diabetes
atrial fibrillation
toll like receptor
cardiovascular disease
acute heart failure